<DOC>
	<DOC>NCT02548845</DOC>
	<brief_summary>In 2014, the Spanish Sociedad Española de Oncología Médica (SEOM) algorithm for the treatment of hyponatraemia secondary to to syndrome of inappropriate antidiuretic hormone (SIADH) in oncology patients was developed. Since it is hypothesised that the adherence to the SEOM algorithm is not 100%, the current retrospective non-interventional study will investigate the perceived and actual adherence of participating centres to the SEOM algorithm and its impact on patient outcomes</brief_summary>
	<brief_title>An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain</brief_title>
	<detailed_description />
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Inappropriate ADH Syndrome</mesh_term>
	<criteria>Provision of patient informed consent unless a) not required by local regulations, b) it would represent a nonreasonable effort or c) if the source patient is deceased or untraceable. Female and/or male oncology patients aged 18 years and over Patients who have experienced at least one occurrence of hyponatraemia secondary to the SIADH. A patient cannot take part in this study if participating in any clinical study in which the medicinal product aims to treat the causes or symptoms of hyponatraemia at the time of the hyponatraemia episode being documented in the current study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>hyponatremia</keyword>
	<keyword>SIADH</keyword>
	<keyword>Oncologic patients</keyword>
</DOC>